GSK-3β inhibitor suppresses symptom onset and progression of ALS model mice

초록

: Glycogen synthase kinase (GSK)-3β has recently been emphasized as an important pathogenic mechanism in neurodegenerative diseases. Although the neuroprotective effects of GSK-3β inhibitors in Alzheimer`s disease have been demonstrated